FDA approves St. Jude Medical’s CRT software
The FDA approved St. Jude Medical’s SyncAV cardiac resynchronization therapy (CRT) software July 11 for independent use or with the company’s MultiPoint pacing technology.
The software, which is intended for patients with heart failure, adjusts pacing based on the patient's cardiac condition. Physicians can use the technology in patients who have responded positively to CRT.
In February, the FDA approved the MultiPoint pacing technology, which is included in the company’s Quadra Assura MP CRT defibrillator, Quadra Allure MP CRT pacemaker and quadripolar Quartet LV leads.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.